Humacyte, Inc. SEC filings HUMA
Humacyte, Inc. has 504 filings in SEC EDGAR's recent list, going back to Aug 4, 2020. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jun 11, 2026 | — |
| 424B5 | Prospectus supplement | Jun 10, 2026 | — |
| S-8 | Employee stock plan registration | May 14, 2026 | — |
| 424B3 | Prospectus | Mar 19, 2026 | — |
| 424B5 | Prospectus supplement | Dec 16, 2025 | — |
| 424B3 | Prospectus | Dec 15, 2025 | — |
| 424B3 | Prospectus | Oct 7, 2025 | — |
| 424B3 | Prospectus | Sep 22, 2025 | — |
| S-3 | Shelf registration | Sep 12, 2025 | — |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| 424B3 | Prospectus | Mar 25, 2025 | — |
| 424B3 | Prospectus | Nov 14, 2024 | — |
| 424B3 | Prospectus | Oct 4, 2024 | — |
| 424B3 | Prospectus | Sep 25, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| 424B3 | Prospectus | Jun 22, 2023 | — |
| S-3 | Shelf registration | Jun 9, 2023 | — |
| POS AM | Filing | Sep 12, 2022 | — |
| 424B3 | Prospectus | Sep 9, 2022 | — |
| 424B3 | Prospectus | Sep 9, 2022 | — |
| S-3 | Shelf registration | Sep 1, 2022 | — |
| S-3 | Shelf registration | Sep 1, 2022 | — |
| 424B3 | Prospectus | Aug 12, 2022 | — |
| 424B3 | Prospectus | Jun 13, 2022 | — |
| 424B3 | Prospectus | May 13, 2022 | — |
| 424B7 | Filing | Apr 4, 2022 | — |
| POS AM | Filing | Mar 30, 2022 | — |
| 424B7 | Filing | Dec 10, 2021 | — |
| POS AM | Filing | Nov 19, 2021 | — |
| S-8 | Employee stock plan registration | Oct 28, 2021 | — |
| 424B7 | Filing | Oct 27, 2021 | — |
| S-1/A | Amended registration statement | Oct 22, 2021 | — |
| S-1 | Registration statement | Sep 17, 2021 | — |
| 424B3 | Prospectus | Aug 4, 2021 | — |
| S-4/A | Registration statement | Aug 2, 2021 | — |
| S-4/A | Registration statement | Jul 23, 2021 | — |
| S-4/A | Amendment no 2 to s-4 | Jul 1, 2021 | — |
| S-4/A | Registration statement | Jun 14, 2021 | — |
| S-4 | Registration for a merger or exchange | Mar 23, 2021 | — |
| 424B4 | Prospectus | Sep 18, 2020 | — |
| S-1/A | Amended registration statement | Sep 14, 2020 | — |
| S-1/A | Amended registration statement | Sep 1, 2020 | — |
| S-1 | Registration statement | Aug 4, 2020 | — |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- HUMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1818382
- Former names
- Alpha Healthcare Acquisition Corp. (until Aug 26, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.